Fri.Dec 22, 2023

article thumbnail

CEO Succession and The Walt Disney Company

Harvard Corporate Governance

Posted by David F. Larcker and Brian Tayan (Stanford University), on Friday, December 22, 2023 Editor's Note: David F. Larcker is the James Irvin Miller Professor of Accounting, Emeritus; and Brian Tayan is a researcher with the Corporate Governance Research Initiative at Stanford Graduate School of Business. This post is based on their recent paper.

300
300
article thumbnail

Investor Sues Illumina, Ex-Execs Over Unwound Grail Deal

Law 360 M&A

An Illumina Inc. investor is piggybacking off of Carl Icahn's suit against the company, alleging in a proposed class action this week that Illumina insiders profited from the company's ill-fated acquisition of cancer test-maker Grail Inc. and then lied about it to investors.

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Weekly Roundup: December 15-21, 2023

Harvard Corporate Governance

Posted by the Harvard Law School Forum on Corporate Governance, on Friday, December 22, 2023 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of December 15-21, 2023 Investor Alliances: The Infrastructure For Climate Stewardship Posted by Amelia Miazad (University of California at Davis), on Friday, December 15, 2023 Tags: Climate change , climate risk , ESG , investor stewardship , investors Securities and Derivative Litigation: Quarterly Upd

Dividends 100
article thumbnail

The Most-Read Legal Industry Law360 Guest Articles Of 2023

Law 360 M&A

A range of legal industry topics drew readers' attention in Law360's Expert Analysis section this year, from associate retention strategies to ethical billing practices.

98
article thumbnail

How to Leverage Intent Data for Better Outcomes

Speaker: Susan Spencer, Principal of Spencer Communications

Intent signal data can go a long way toward shortening sales cycles and closing more deals. The challenge is deciding which is the best type of intent data to help your company meet its sales and marketing goals. In this webinar, Susan Spencer, fractional CMO and principal of Spencer Communications, will unpack the differences between contact-level and company-level intent signals.

article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by Russell

Appraisers Blog

In reply to Older and Maybe Wiser. If you are unable to tell when you get there and they fit the class. Simply say I am feeling sick and leave. Tell the client it is not to your best interest at this time to complete the report. I have told vendors that “not to my best interest many times.

article thumbnail

Payment integrity in the age of AI and value-based care

Mckinsey and Company

The rise of AI and value-based care is poising the $9 billion payment integrity industry for change.

94

More Trending

article thumbnail

Short-Term Business Loans: Can Fast Financing Help Your Startup Grow?

Lighter Capital

Today’s SaaS entrepreneurs have extensive options for securing debt capital to extend runway, fund working capital, and help achieve almost any business goal. Prominent SaaS financing solutions feature a straightforward application process, fast funding, flexible repayment terms, and, most important, zero equity dilution. Short-term financing (12 months or less), which includes merchant cash advances (MCA) and merchant financing, often attracts startup founders looking for lower capital costs an

Finance 59
article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by Krystal

Appraisers Blog

Absolute moronic insanity. It PROVES that no one outside of those trained in valuation have ANY clue how appraising works. Our job is and has never been to try to INFLATE an appraisal to make all recipients of an appraisal ‘happy’ no matter what, to avoid being sued or fined. Our job is and has ALWAYS been to provide an UNBIASED, fact-based opinion of value-based on the available market data.

article thumbnail

Vestd 2023: the new and improved

Vested

2023 at Vestd: a year of innovation and improvements. Discover enhanced shareholder communication, secure data rooms, and more, plus what's coming in 2024!

59
article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by JohnnyQ

Appraisers Blog

"Well, I guess no one will be doing appraisals in New Jersey. or maybe the standard fee is going to be $10,000?" said one appraiser.

article thumbnail

Statement of Cash Flows vs. Cash Flow Statement

Speaker: Wayne Spivak - President and Chief Financial Officer of SBA * Consulting LTD, Industry Writer, and Public Speaker

The old adages that "cash is king" and "you can’t spend profits" still hold true today. But however well-known these sayings might be, it requires a change in mindset to properly implement a cash flow management system that predicts your business's runaway as accurately as possible. Key to this new mindset is understanding the difference between the Statement of Cash Flows, a historical look at the source and uses of cash, and the Cash Flow Statement, which uses transaction history and forward-l

article thumbnail

Simon Robey scores £20mn payday as Robey Warshaw profits climb

Financial Times M&A

The boutique firm where George Osborne is a partner posted a 5.

96
article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by Mary Thompson

Appraisers Blog

In reply to Older and Maybe Wiser. …and this is the other unintended consequence; not enough Appraisers to do the work as many will avoid any areas that could be an issue. Then they will complain that Appraisers are avoiding them or that the time is extended trying to find an Appraiser to do the job. They want to sue us and we can make that impossible for them to do by refusing the job.

article thumbnail

New York hospitals face new cybersecurity rules. Will other states follow?

LaPorte

(authored by RSM US LLP) In an effort to combat cyber threats, New York state has proposed new regulations applicable to all hospitals in the state. The post New York hospitals face new cybersecurity rules. Will other states follow? first appeared on LaPorte.

52
article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by LaydeeTee

Appraisers Blog

In reply to Mark S. Davis. Unfortunately, You are exactly right. ? They don’t want an independent, neutral professional. They want control… and it’s coming.

article thumbnail

Mastering Intent Data: Understanding its Importance & Best Practices

Speaker: Joe Apfelbaum, CEO of Ajax Union

In this webinar, Joe Apfelbaum, CEO of Ajax Union and business strategist, will take you through the ABCs of intent data. You'll learn how to effectively use it to drive business results, with practical tips on how to leverage both company and contact intent data to maximize your marketing efforts. Whether you're a seasoned marketer or just getting started, this webinar is a must-attend for anyone looking to stay ahead in the ever-evolving world of digital marketing.

article thumbnail

2023 Top 3 tax management webcasts

ThomsonReuters

As emerging technologies continue to reshape industries, tax departments are not exempt from the transformative power of innovation. In this era of rapid change, corporate tax professionals must stay ahead of the curve and leverage the latest tools and strategies to navigate the complex landscape of tax compliance. To help you gain valuable insights and stay informed about the latest trends, we are excited to present a series of our top 3 webcasts featuring leading subject matter experts.

article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by Mark Page

Appraisers Blog

Yes, there is still active and systemic racism in this country and will be for years to come. However with all of the current oversight, UAD checks and balances and algorithm and human review I do not think it is in any way possible to perpetually over/under value properties. It just isn’t possible and certainly not on any large scale basis. This entire concept is flawed IMO.

article thumbnail

New Year, New Business: Top Industries to Buy into in 2024

Hallmark Brokers

Confetti’s settled, resolutions are set, and the tantalizing possibilities of a fresh year shimmer before us. For many, that includes the thrilling entrepreneurial itch – a burning desire to become their own boss. But with countless industries vying for your attention, which one promises the sweetest success in 2024? Here at Hallmark Business Brokers, we’ve.

52
article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by Mary T Thompson

Appraisers Blog

So this is what would happen if something like this were passed. Protected classes of homeowners (IF the Appraiser knows the race of the homeonwers) will be over valued, because Appraisers cannot afford to be sued and pay $25,000 to $50,000 for an offense that they cannot prove. Then a few years down the line when they cannot sell their homes, they go into foreclosure and they will…you guessed it…BLame the Appraiser once again but this time for OVER-VALUATION of the “protected

article thumbnail

Insurance Company Fanhua Streamlines Its Ownership Structure In Puyi: Details

Benzinga

Puyi Inc (NASDAQ: PUYI ) disclosed signing an agreement with Fanhua Inc (NASDAQ: FANH ) to repurchase its 4.46% stake. Concurrently, Puyi entered into a share transfer agreement with Fanhua, as per which Fanhua's subsidiary in China will. Full story available on Benzinga.

Equity 52
article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by KK

Appraisers Blog

In reply to Seneca. Bingo. They want appraisers gone so that they can line their pockets faster, without as reliable, credible, unbiased party being a cog on the wheel to halt when the consumer is being railroaded into a bad loan that is unsupported by the market.

article thumbnail

With Karuna Therapeutics $14B Deal, Bristol Myers Is Serious For Re-Establishing Its Neurology Portfolio: Analyst

Benzinga

Earlier Friday, Bristol Myers Squibb & Co (NYSE: BMY ) agreed to acquire Karuna Therapeutics Inc (NASDAQ: KRTX ) for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 billion net of estimated cash acquired. William Blair highlights Bristol Myers' commitment to reestablishing its neuroscience pipeline as a primary focus during the 2023 R&D event.

Equity 52
article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by Mark S. Davis

Appraisers Blog

A rational analysis of this bill results in a conclusion that the people issuing it are ignorant morons if not completely insane, however, that assumes they care about any of the parties involved and have good intentions. But their (puppet-masters) purposes are not what they state, it is to eliminate appraisals completely paving the way for more and bigger loans to people who will default (as noted above) and implement the Great Reset (You will own nothing and be happy!).

article thumbnail

‘Twas the Blog before Christmas….

Auto Dealer Valuation Insights

It has become a tradition for the RIA team at Mercer Capital to end the blog year with a “unique” annual summary of industry events, riffing off Clement Clark Moore’s classic “A Visit from St. Nicholas.” We hope all of you in the investment management community are enjoying the holiday season and looking forward to the many opportunities of the new year.

52
article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by Seneca

Appraisers Blog

Hilarious they think there will ever be a second and third offense. Who is sticking around in this profession after a $10,000 fine? Or any profession. At least I live in a state to where this craziness will never happen.

article thumbnail

Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash

Benzinga

Theseus Pharmaceuticals Inc (NASDAQ: THRX ) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and $4.05 in cash, consisting of a base cash price of $3.90 per share and an additional cash amount of not more than $0.15 per share at the closing of the merger, plus one non-tradeable contingent value right (CVR).

Equity 52
article thumbnail

Covington-Led Bristol Myers To Buy Karuna In $14B Deal

Law 360 M&A

Covington & Burling LLP-advised Bristol Myers Squibb said Friday it has agreed to buy Boston-based biotechnology company Karuna Therapeutics Inc. for $14 billion, leading Karuna's stock to jump more than 47% in pre-market trading.

article thumbnail

Bristol Myers Squibb Scoops Up Schizophrenia Player Karuna Therapeutics In Massive $14B Deal

Benzinga

On Friday, Bristol Myers Squibb & Co (NYSE: BMY ) agreed to acquire Karuna Therapeutics Inc (NASDAQ: KRTX ) for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 billion net of estimated cash acquired. Karuna is focused on developing treatments for psychiatric and neurological conditions. Karuna's lead asset, KarXT (xanomeline-trospium), is an antipsychotic.

Equity 52
article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by Seneca

Appraisers Blog

"Well, I guess no one will be doing appraisals in New Jersey. or maybe the standard fee is going to be $10,000?" said one appraiser.

article thumbnail

Lionsgate Forms $4.6B Studio Giant with Screaming Eagle SPAC Merger

Benzinga

Lionsgate Entertainment Corp (NYSE: LGF-A ) (NYSE: LGF-B ) announced that it would merge its Studio Business, which includes its Television Studio, Motion Picture Group segments, and an extensive film and television library, with special purpose acquisition company (SPAC) Screaming Eagle Acquisition Corp (NASDAQ: SCRM ) to form Lionsgate Studios Corp.

52
article thumbnail

Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

NYT M&A

The deal is a bet on the growing market for psychiatric and neurological drugs.

article thumbnail

Dada Nexus Rides Closer To JD.com's Orbit With Management Shakeup

Benzinga

Key Takeaways: Dada Nexus has appointed two JD Logistics veterans as its new chairman and CFO, hinting at closer integration between the two companies The intra-city delivery company has become more integrated with JD.com since JD boosted its stake in Dada Nexus to 52% last year from a previous 47% By Doug Young Things got quite personal this week at local delivery company Dada Nexus Ltd.

article thumbnail

Comment on New Jersey Draconian Penalties on Appraisers by Mike Smiley

Appraisers Blog

"Well, I guess no one will be doing appraisals in New Jersey. or maybe the standard fee is going to be $10,000?" said one appraiser.

article thumbnail

Health Care Company Bristol-Myers Squibb Announces Merger With Karuna Therapeutics

Benzinga

Bristol-Myers Squibb (NYSE: BMY ) has announced a merger with Karuna Therapeutics (NASDAQ: KRTX ) that is expected to be completed 2024-H1. Under the terms of the agreement, Bristol-Myers Squibb has agreed to give Karuna Therapeutics $14.00 billion in cash in exchange for KRTX stock. About The Companies Involved Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders.

article thumbnail

Private Equity Veteran Joins Blank Rome in Houston

Law 360 M&A

Blank Rome LLP has hired a private equity expert as senior counsel in its Houston office who spent the last 25 years at investment fund Milestone Capital Inc.

Equity 52